Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?

BACKGROUND: Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease worldwide. Renin-angiotensin system (RAS) inhibitors are the first-line treatment for diabetic patients with hypertension. However, whether RAS inhibitors prevent the development of DKD remains controversial. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Hiroki, Babazono, Akira, Nishi, Takumi, Maeda, Toshiki, Imatoh, Takuya, Ichiba, Masayoshi, Une, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567802/
https://www.ncbi.nlm.nih.gov/pubmed/26362195
http://dx.doi.org/10.1186/s40360-015-0024-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567802/
https://www.ncbi.nlm.nih.gov/pubmed/26362195
http://dx.doi.org/10.1186/s40360-015-0024-y

Ejemplares similares